TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 92 filers reported holding TANGO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $14 | +7.7% | 1,618 | 0.0% | 0.00% | – |
| Q1 2024 | $13 | -67.5% | 1,618 | -59.6% | 0.00% | – |
| Q4 2023 | $40 | -21.6% | 4,007 | -10.7% | 0.00% | – |
| Q3 2023 | $51 | +240.0% | 4,489 | 0.0% | 0.00% | – |
| Q2 2023 | $15 | -21.1% | 4,489 | -7.0% | 0.00% | – |
| Q1 2023 | $19 | -55.8% | 4,825 | -18.3% | 0.00% | – |
| Q4 2022 | $43 | -99.8% | 5,906 | 0.0% | 0.00% | – |
| Q3 2022 | $21,000 | -22.2% | 5,906 | 0.0% | 0.00% | – |
| Q2 2022 | $27,000 | – | 5,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,201,475 | $164,748,656 | 81.48% |
| Mass General Brigham, Inc | 354,192 | $3,038,967 | 14.80% |
| Nextech Invest Ltd. | 5,533,980 | $47,481,548 | 7.99% |
| Boxer Capital, LLC | 8,198,642 | $70,344,348 | 3.70% |
| EcoR1 Capital, LLC | 13,330,736 | $114,377,715 | 3.50% |
| Braslyn Ltd. | 26,961 | $231,325 | 2.77% |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $24,819,049 | 2.72% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 115,571 | $991,599 | 1.25% |
| Samsara BioCapital, LLC | 630,000 | $5,405,400 | 1.13% |
| Southpoint Capital Advisors LP | 5,276,699 | $45,274,077 | 1.13% |